Rapida-acting insulin pen. (Products).
Novolog (insulin aspart, [rDNA origin] injection), a rapid-acting insulin analogue, is now available in the FlexPen prefilled syringe for treating diabetes. With faster absorption and onset, and a shorter duration of action, the insulin analog is suited for mealtime bolus dosing to control postprandial glycemia. The prefilled 3-mL pen can be used for 28 days without refrigeration, and provides doses in one-unit increments up to 60 units per injection (each pen contains 300 units). For more information, contact Novo Nordisk Pharmaceuticals Inc., 800-727-6500, www.novolog.com.
|Printer friendly Cite/link Email Feedback|
|Publication:||Internal Medicine News|
|Article Type:||Brief Article|
|Date:||Jul 1, 2003|
|Previous Article:||New antivomiting agent. (Products).|
|Next Article:||Office flags and alerts. (Products).|